New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools
Authors
Keywords
Ovarian cancer, Cancer stem cells, Biomarkers, Therapy
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-04
DOI
10.1186/s13046-019-1245-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells – An updated review
- (2018) Thingreila Muinao et al. EXPERIMENTAL CELL RESEARCH
- Molecular mechanisms of drug resistance in ovarian cancer
- (2018) Leyla Norouzi-Barough et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Chemoresistance in ovarian cancer: exploiting cancer stem cell metabolism
- (2018) Shan-Shan Li et al. Journal of Gynecologic Oncology
- Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
- (2018) Jiayu Shen et al. OncoTargets and Therapy
- Are ovarian cancer stem cells the target for innovative immunotherapy?
- (2018) Liang Wang et al. OncoTargets and Therapy
- DNA damage repair in ovarian cancer: unlocking the heterogeneity
- (2018) Mary Ellen Gee et al. Journal of Ovarian Research
- Challenges and controversies in the conservative management of uterine and ovarian cancer
- (2018) M. Janda et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Surgical prevention strategies in ovarian cancer
- (2018) Adrianne Mallen et al. GYNECOLOGIC ONCOLOGY
- GLOBOCAN 2018: counting the toll of cancer
- (2018) The Lancet LANCET
- Ovarian cancer stem cells: A target for oncological therapy
- (2018) Anna Markowska et al. Advances in Clinical and Experimental Medicine
- Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
- (2018) Lynn Roy et al. Cancers
- Overview of CD24 as a new molecular marker in ovarian cancer
- (2018) Vahideh Tarhriz et al. JOURNAL OF CELLULAR PHYSIOLOGY
- CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
- (2017) Kiyoko Nakamura et al. ONCOLOGY REPORTS
- Ovarian cancer stem cells more questions than answers
- (2017) Petronella Beatrix Ottevanger SEMINARS IN CANCER BIOLOGY
- Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells
- (2017) Anna Pagotto et al. Cell Death & Disease
- Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
- (2017) Manuel-Pedro Jiménez-García et al. Oncotarget
- Gene Expression Profiling Reveals Novel Candidate Markers of Ovarian Carcinoma Intraperitoneal Metastasis
- (2017) Katerina Elsnerova et al. Journal of Cancer
- Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells
- (2016) Kamola Saydaminova et al. CANCER BIOLOGY & THERAPY
- The cancer stem-cell signaling network and resistance to therapy
- (2016) A. Carnero et al. CANCER TREATMENT REVIEWS
- Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions
- (2016) Nicolette G. Alkema et al. DRUG RESISTANCE UPDATES
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Cisplatin induces stemness in ovarian cancer
- (2016) Andrew Wiechert et al. Oncotarget
- Ovarian cancer
- (2016) Ursula A. Matulonis et al. Nature Reviews Disease Primers
- Tumorspheres Derived from HCC Cells are Enriched with Cancer Stem Cell-like Cells and Present High Chemoresistance Dependent on the Akt Pathway
- (2015) Xiao-Li Zhang et al. Anti-Cancer Agents in Medicinal Chemistry
- Discovery of microarray-identified genes associated with ovarian cancer progression
- (2015) XIA LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs
- (2015) Che-Hsin Lee et al. Oncotarget
- Identification of a distinct population of CD133+CXCR4+ cancer stem cells in ovarian cancer
- (2015) Michele Cioffi et al. Scientific Reports
- Oncogenes associated with drug resistance in ovarian cancer
- (2014) Xia Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- A New Tumorsphere Culture Condition Restores Potentials of Self-Renewal and Metastasis of Primary Neuroblastoma in a Mouse Neuroblastoma Model
- (2014) Dongliang Cao et al. PLoS One
- Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
- (2014) Christen L Walters Haygood World Journal of Stem Cells
- Ovarian cancer stem cell markers: Prognostic and therapeutic implications
- (2012) Daniela Burgos-Ojeda et al. CANCER LETTERS
- Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties
- (2012) Linlin Zhang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Chemotherapy in epithelial ovarian cancer
- (2011) Sandro Pignata et al. CANCER LETTERS
- Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
- (2011) A. D. Steg et al. CLINICAL CANCER RESEARCH
- Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells
- (2011) Ilona Kryczek et al. INTERNATIONAL JOURNAL OF CANCER
- Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
- (2011) Sandro Pignata et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now